We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
XOLAIR omalizumab (rch) 300 mg solution for injection pre-filled syringe (2024-25)
Product name
XOLAIR omalizumab (rch) 300 mg solution for injection pre-filled syringe
Sponsor name
Novartis Pharmaceuticals Australia Pty Ltd
Year Range
2024-25